Innovating Works

Olomedia

Desconocido
REVERT: taRgeted thErapy for adVanced colorEctal canceR paTients OLOMEDIA SRL participó en un H2020: H2020-SC1-BHC-2018-2020 The REVERT project will address the specific challenge of understanding at system level the pathophysiology of mCRC cancer in patients respo...
2019-11-22 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.